Key Points: In today’s Recommendations for Industry, we discuss a return to normal. Read more below. In a recent paper published in JAMA Neurology, CIDRAP
Key Points: In today’s Recommendations for Industry, we discuss combatting infectious diseases in the world’s “next normal.” Read more below. The pandemic global death rate
Key Points: In today’s Recommendations for Industry, we discuss CDC’s new masking guidance and the utilization of the County-Searchable Tool. Read more below. A recent
Key Points: In today’s Recommendations for Industry, we discuss the current “transition” status of COVID-19, mask mandates, and recommendations. Read more below. Is the Coronavirus
Key Points: In today’s Recommendations for Industry, we discuss TAG’s matrix and the current trends of COVID and its variants. Read more below. As countries
Key Points: In today’s Recommendations for Industry, we discuss the current progression of COVID and the flu and why keeping calm is the phrase of
Key Points: In today’s Recommendations for Industry, we discuss the business management of COVID’s next wave … whatever that may be. Read more below. As
Key Points: In today’s Recommendations for Industry, we discuss new studies suggesting that flu shots, measles vaccines, and the common cold can cross-protect against COVID.
Key Points: In today’s Recommendations for Industry, we discuss the Omicron variant. Read more below. On Sunday Jan 09, the CDC updated its “Quarantine and
Key Points: In today’s Recommendations for Industry, we discuss testing symptomatic employees prior to their return to work. Read more below. South Africa has declared